Wells Fargo & Company »

Fusion Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Fusion Pharmaceuticals (FUSN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Fusion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fusion Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fusion Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $48k 5.0k 9.61
2022-06-30 $0 0 0.00
2020-06-30 $271k 16k 17.47

More positions owned by Wells Fargo & Company

Microsoft Corporation Put Option (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Amazon Put Option (AMZN)
Vanguard Index Fds Mid Cap Etf Put Option (VO)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p Ttl Stk (ITOT)
UnitedHealth Call Option (UNH)
JPMorgan Chase & Co. Put Option (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Johnson & Johnson (JNJ)

View all positions for Wells Fargo & Company

Top funds holding Fusion Pharmaceuticals

Federated Investors
Avidity Partners Management
Deerfield Management Company
OrbiMed Advisors
Perceptive Advisors
Tpg Gp A
Sphera Funds Management
Artal Group
William Blair $ Company
Wellington Management Company
Eagle Health Investments
Millennium Management
Ikarian Capital
Marshall Wace
Fred Alger Management

View all funds holding Fusion Pharmaceuticals